<DOC>
	<DOC>NCT02277158</DOC>
	<brief_summary>The purpose of this study is to determine the maximum tolerated dose and safety of S-1 plus radiotherapy for patients with rectal cancer</brief_summary>
	<brief_title>Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.</brief_title>
	<detailed_description>This stage I study is designed to evaluate the appropriate dose of S-1 plus radiotherapy for patients with R0 resection of rectal cancer for stage II-III patients(AJCC 7th). To evaluate safety, data on adverse events will be collected from the time of enrollment until withdrawn of complete whole study.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>R0 resection of histologically proved stage II/III rectal cancer; 1875 years old; No previous radiotherapy or chemotherapy for rectal cancer; Performance status of ECOG 0,1; Adequate organ function defined as below: i. WBC ≥ 4,000/mm^3 ii. ANC ≥ 1,500/mm^3 iii. Hemoglobin ≥ 10g/dL iv. Platelet ≥ 100,000/m^3 v. Total bilirubin ≤ 1.5ULN vi. AST/ALT ≤ 1.5ULN vii. Serum creatinine ≤ 1.5ULN or creatinine clearance rate ≥ 60ml/min、Urea nitrogen ≤ 1.5ULN viii. Protein in urine dipstick test＜1+; if the test result ＞1+ ,total protein in urea must ＜500mg within 24 hours Able to receive oral administration Informed consent Hypersensitive to S1 or its excipients Pulmonary fibrosis or interstitial pneumonitis found within 28 days prior to registration Significant comorbid medical conditions, including, but not limited to, heart failure, renal failure, hepatic failure, hemorrhagic peptic ulcer, mechanical or paralytic ileus, or poorly controlled diabetes Received any investigational drug or anticancer agent Pregnant or lactating female or pregnancy test positive Severe mental disorder Judged ineligible by physicians for participation in the study due to safety concern.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>S-1</keyword>
	<keyword>Chemoradiotherapy</keyword>
	<keyword>Phase I</keyword>
</DOC>